1
|
Aboyans V, Vrsalovic M, Madaric J, Mazzolai L, De Carlo M. The year 2018 in cardiology: aorta and peripheral circulation. Eur Heart J 2019; 40:872-879. [DOI: 10.1093/eurheartj/ehy899] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/03/2018] [Revised: 11/29/2018] [Accepted: 12/22/2018] [Indexed: 12/24/2022] Open
Affiliation(s)
- Victor Aboyans
- Department of Cardiology, Dupuytren University Hospital, 2, Martin Luther King Ave, Limoges, France
- Research Unit INSERM 1094, Limoges School of Medicine, 2, ave Marcland, Limoges, France
| | - Mislav Vrsalovic
- University of Zagreb School of Medicine, Salata 3, Zagreb, Croatia
- Department of Cardiology, Sestre Milosrdnice University Hospital Centre, Vinogradska 29, Zagreb, Croatia
| | - Juraj Madaric
- Department of Cardiology and Angiology, National Institute of Cardiovascular Diseases, Pod Krasnou horkou 1, Bratislava, Slovakia
| | - Lucia Mazzolai
- Division of Angiology, Heart and Vessel Department, Lausanne University Hospital, Rue du Bugnon 46, Lausanne, Switzerland
| | - Marco De Carlo
- Cardiac Catheterization Laboratory, Cardiothoracic and Vascular Department, Azienda Ospedaliero-Universitaria Pisana, via Paradisa 2, Pisa, Italy
| | | |
Collapse
|
2
|
De Carlo M, Mazzolai L, Bossone E, Brodmann M, Micari A, Muiesan ML, Ricco JB, Stabile E, Agnelli G, Aboyans V. The year in cardiology 2016: peripheral circulation. Eur Heart J 2018; 38:1028-1033. [PMID: 28043979 DOI: 10.1093/eurheartj/ehw643] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/21/2016] [Accepted: 12/28/2016] [Indexed: 01/16/2023] Open
Affiliation(s)
- Marco De Carlo
- Cardiac Catheterization Laboratory, Cardiothoracic and Vascular Department, Azienda Ospedaliero-Universitaria Pisana, via Paradisa 2, 56100 Pisa, Italy
| | - Lucia Mazzolai
- Department of Angiology, Lausanne University Hospital, Rue du Bugnon 46, 1011 Lausanne, Switzerland
| | - Eduardo Bossone
- Cardiology Division, "Cava de' Tirreni and Amalfi Coast", Heart Department, University Hospital, Via Enrico de Marinis, 84013 Cava de' Tirreni (SA), Italy
| | - Marianne Brodmann
- Division of Angiology, Medical University Graz, Auenbruggerplatz 15, 8036 Graz, Austria
| | - Antonio Micari
- GVM Care and Research, Maria Cecilia Hospital, via Corriera 1, 48033 Cotignola (RA), Italy
| | - Maria Lorenza Muiesan
- Clinical and Experimental Sciences Department, University of Brescia, Piazzale Spedali Civili 1, 25123 Brescia, Italy
| | - Jean-Baptiste Ricco
- Department of Vascular Surgery, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France
| | - Eugenio Stabile
- Division of Cardiology, Department of Advanced Biomedical Sciences, University of Napoli "Federico II", Corso Umberto I 40, 80138 Napoli, Italy
| | - Giancarlo Agnelli
- Internal and Cardiovascular Medicine - Stroke Unit, University of Perugia, Viale Zefferino Faina 4, 06123 Perugia, Italy
| | - Victor Aboyans
- Department of Cardiology, Dupuytren University Hospital, Limoges, and Inserm 1094, Tropical Neuroepidemiology, University of Limoges, 33 Rue François Mitterrand, 87032 Limoges, France
| | | |
Collapse
|
3
|
Hrbáč T, Netuka D, Beneš V, Nosáľ V, Kešnerová P, Tomek A, Fadrná T, Beneš V, Fiedler J, Přibáň V, Brozman M, Langová K, Herzig R, Školoudík D. SONOlysis in prevention of Brain InfaRctions During Internal carotid Endarterectomy (SONOBIRDIE) trial - study protocol for a randomized controlled trial. Trials 2017; 18:25. [PMID: 28095924 PMCID: PMC5240392 DOI: 10.1186/s13063-016-1754-x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2016] [Accepted: 12/12/2016] [Indexed: 11/17/2022] Open
Abstract
BACKGROUND Carotid endarterectomy (CEA) is a beneficial procedure for selected patients with an internal carotid artery (ICA) stenosis. Surgical risk of CEA varies from between 2 and 15%. The aim of the study is to demonstrate the safety and effectiveness of sonolysis (continual transcranial Doppler monitoring, TCD) using a 2-MHz diagnostic probe with maximal diagnostic energy on the reduction of the incidence of stroke, transient ischemic attack (TIA) and brain infarction detected using magnetic resonance imaging (MRI) by the activation of the endogenous fibrinolytic system during CEA. METHODS/DESIGN Design: a multicenter, randomized, double-blind, sham-controlled trial. SCOPE international, multicenter trial for patients with at least 70% symptomatic or asymptomatic ICA stenosis undergoing CEA. INCLUSION CRITERIA patients with symptomatic or asymptomatic ICA stenosis of at least 70% are candidates for CEA; a sufficient temporal bone window for TCD; aged 40-85 years, functionally independent; provision of signed informed consent. Randomization: consecutive patients will be assigned to the sonolysis or control (sham procedure) group by computer-generated 1:1 randomization. Prestudy calculations showed that a minimum of 704 patients in each group is needed to reach a significant difference with an alpha value of 0.05 (two-tailed) and a beta value of 0.8 assuming that 10% would be lost to follow-up or refuse to participate in the study (estimated 39 endpoints). ENDPOINTS the primary endpoint is the incidence of stroke or TIA during 30 days after CEA and the incidence of new ischemic lesions on brain MRI performed 24 h after CEA in the sonolysis and control groups. Secondary endpoints are occurrence of death, any stroke, or myocardial infarction within 30 days, changes in cognitive functions 1 year post procedure related to pretreatment scores, and number of new lesions and occurrence of new lesions ≥0.5 mL on post-procedural brain MRI. ANALYSIS descriptive statistics and linear/logistic multiple regression models will be performed. Clinical relevance will be measured as relative risk reduction, absolute risk reduction and the number needed to treat. DISCUSSION Reduction of the periprocedural complications of CEA using sonolysis as a widely available and cheap method may significantly increase the safety of CEA and extend the indication criteria for CEA. TRIAL REGISTRATION ClinicalTrials.gov, NCT02398734 . Registered on 20 March 2015.
Collapse
Affiliation(s)
- Tomáš Hrbáč
- Department of Neurosurgery, Comprehensive Stroke Center, University Hospital Ostrava, Ostrava, Czech Republic
| | - David Netuka
- Department of Neurosurgery and Neurooncology, Comprehensive Stroke Center, Military University Hospital, Prague, Czech Republic
| | - Vladimír Beneš
- Department of Neurosurgery and Neurooncology, Comprehensive Stroke Center, Military University Hospital, Prague, Czech Republic
| | - Vladimír Nosáľ
- Department of Neurology, Jessenius Faculty of Medicine in Martin, Comenius University, Bratislava, Slovak Republic
| | - Petra Kešnerová
- Department of Neurology, Comprehensive Stroke Center, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic
| | - Aleš Tomek
- Department of Neurology, Comprehensive Stroke Center, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic
| | - Táňa Fadrná
- Department of Neurosurgery, Comprehensive Stroke Center, University Hospital Ostrava, Ostrava, Czech Republic
- Center for Research and Science, Faculty of Health Sciences, Palacký University Olomouc, Olomouc, Czech Republic
| | - Vladimír Beneš
- Department of Neurosurgery, Comprehensive Stroke Center, Liberec Hospital, Liberec, Czech Republic
| | - Jiří Fiedler
- Department of Neurosurgery, Comprehensive Stroke Center, České Budějovice Hospital, České Budějovice, Czech Republic
- Department of Neurosurgery, Comprehensive Stroke Center, University Hospital Plzeň, Plzeň, Czech Republic
| | - Vladimír Přibáň
- Department of Neurosurgery, Comprehensive Stroke Center, University Hospital Plzeň, Plzeň, Czech Republic
| | - Miroslav Brozman
- Department of Neurology, Faculty Hospital Nitra, Constantine Philosopher University Nitra, Nitra, Slovakia
| | - Kateřina Langová
- Center for Research and Science, Faculty of Health Sciences, Palacký University Olomouc, Olomouc, Czech Republic
- Department of Biophysics, Faculty of Medicine and Dentistry, Institute of Molecular and Translational Medicine, Palacký University, Olomouc, Czech Republic
| | - Roman Herzig
- Department of Neurosurgery and Neurooncology, Comprehensive Stroke Center, Military University Hospital, Prague, Czech Republic
- Department of Neurology, Comprehensive Stroke Center, Charles University Faculty of Medicine and University Hospital Hradec Králové, Hradec Králové, Czech Republic
| | - David Školoudík
- Center for Research and Science, Faculty of Health Sciences, Palacký University Olomouc, Olomouc, Czech Republic
- Department of Neurology, Comprehensive Stroke Center, University Hospital Ostrava, Ostrava, Czech Republic
| |
Collapse
|